Clinical Trial Update: Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on a broad-spectrum HPV vaccine study in women aged 16-26 has completed enrollment and posted results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Genital Warts
• Human Papillomavirus Infection
• Vaginal Cancer
• Vulvar Cancer

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cervical Cancer, Vulvar Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-12-19